Back to discover

Protein / target

Interferon-induced helicase C domain-containing protein 1

Encoded byIFIH1Q9BYX4Homo sapiensSwiss-Prot
Small-molecule tractable
Druggability
Structure with Ligand
3
Research papers

Protein at a glance

Biological role

Pattern recognition receptor

Strongest disease association

Hypothyroidism

Via encoding gene IFIH1 · Genetic evidence · score 0.83

Research activity

Emerging research

3 papers · latest 2024

Derived from structured UniProt, Open Targets and literature data on this page.

Protein profile

UniProt 2026_02

Canonical identity and biological annotation from UniProt.

Function overview

Innate immune receptor which acts as a cytoplasmic sensor of viral nucleic acids and plays a major role in sensing viral infection and in the activation of a cascade of antiviral responses including the induction of type I interferons and pro-inflammatory cytokines.

View complete UniProt function annotation

Innate immune receptor which acts as a cytoplasmic sensor of viral nucleic acids and plays a major role in sensing viral infection and in the activation of a cascade of antiviral responses including the induction of type I interferons and pro-inflammatory cytokines (PubMed:28594402, PubMed:32169843, PubMed:33727702). Its ligands include mRNA lacking 2'-O-methylation at their 5' cap and long-dsRNA (>1 kb in length) (PubMed:22160685). Upon ligand binding it associates with mitochondria antiviral signaling protein (MAVS/IPS1) which activates the IKK-related kinases: TBK1 and IKBKE which phosphorylate interferon regulatory factors: IRF3 and IRF7 which in turn activate transcription of antiviral immunological genes, including interferons (IFNs); IFN-alpha and IFN-beta. Responsible for detecting the Picornaviridae family members such as encephalomyocarditis virus (EMCV), mengo encephalomyocarditis virus (ENMG), and rhinovirus (PubMed:28606988). Detects coronavirus SARS-CoV-2 (PubMed:33440148, PubMed:33514628). Can also detect other viruses such as dengue virus (DENV), west Nile virus (WNV), and reovirus. Also involved in antiviral signaling in response to viruses containing a dsDNA genome, such as vaccinia virus. Plays an important role in amplifying innate immune signaling through recognition of RNA metabolites that are produced during virus infection by ribonuclease L (RNase L). May play an important role in enhancing natural killer cell function and may be involved in growth inhibition and apoptosis in several tumor cell lines

Subcellular location

CytoplasmNucleusMitochondrion
Domains and Gene Ontology detail (39)

Domains & features

CARD 1CARD 2Helicase ATP-bindingHelicase C-terminalRLR CTR

Gene Ontology

  • Ccytoplasm
  • Ccytosol
  • Cmitochondrion
  • Cnucleus
  • FATP binding
  • FATP hydrolysis activity
  • FDNA binding
  • Fdouble-stranded RNA binding
  • Fidentical protein binding
  • Fpattern recognition receptor activity
  • Fprotein domain specific binding
  • Fribonucleoprotein complex binding

1025 aa · 117 kDa · 2 isoforms

Biological roles

What this protein does, drawn together from its UniProt function, Gene Ontology terms and Reactome pathways.

Immune signallingUniProt · GO
View supporting evidence

Immune signalling

  • ·Innate immune receptor which acts as a cytoplasmic sensor of viral nucleic acids and pla…
  • ·antiviral innate immune response
  • ·innate immune response
  • ·positive regulation of interleukin-6 production

Concepts derived from UniProt GO Reactome — each badge above shows which sources supported that role.

Translational evidence

Open Targets 26

Why this target matters therapeutically, strongest evidence first. Disease associations are gene-level (via the gene that encodes this protein) and open into the full confidence synthesis; the development universe, tractability and safety annotations are target-level, from Open Targets.

Strongest disease associations · via encoding gene IFIH1

Gene-level evidence surfaced through the gene IFIH1that encodes this protein — not a direct protein–disease relationship. Ranked by Forefront's causal-directness weighting, so genetically- and clinically-evidenced diseases lead over ones that merely share the literature.

Hypothyroidism
0.83Well supported

Genetic evidence dominant · Open Targets 0.63

Psoriasis
0.78Well supported

Genetic evidence dominant · Open Targets 0.58

Myxedema
0.74Moderately supported

Genetic evidence dominant · Open Targets 0.56

Thyroid Diseases
0.69Moderately supported

Genetic evidence dominant · Open Targets 0.52

View evidence synthesis (4)
HypothyroidismWell supported
0.83
agreement 0.690.97
Genetic97%Literature3%

Open Targets aggregate 0.63 · 2 independent evidence families

PsoriasisWell supported
0.78
agreement 0.650.90
Genetic90%Literature7%RNA expression3%

Open Targets aggregate 0.58 · 3 independent evidence families

MyxedemaModerately supported
0.74
agreement 0.600.88
Genetic99%Literature1%

Open Targets aggregate 0.56 · 2 independent evidence families

Thyroid DiseasesModerately supported
0.69
agreement 0.570.81
Genetic100%

Open Targets aggregate 0.52 · 1 independent evidence family

The evidence agreement range shows how closely the independent evidence families agree — it is not a statistical confidence interval, and nothing here is fitted to outcome data. Derived from Open Targets evidence types under Forefront weighting; the per-type scores above show the calculation.

Show all associations
Hypothyroidism0.63
Psoriasis0.58
Myxedema0.56
Thyroid Diseases0.52

Tractability

Small moleculesEmerging

Feasibility evidence (structure with ligand) — no clinical-stage drug of this modality recorded.

Protein degradersEmerging

Feasibility evidence (uniprot ubiquitination and database ubiquitination) — no clinical-stage drug of this modality recorded.

View underlying tractability evidence (4)
SM · Structure with LigandPR · UniProt UbiquitinationPR · Database UbiquitinationPR · Half-life Data

Raw Open Targets tractability assessment buckets, by modality.

Research activity

3 papers · to 2024

Papers linked directly to this protein. This is the protein's own literature — descriptor-derived papers are kept separate below.

Most cited

Yoneyama M · Journal of immunology (Baltimore, Md. : 1950) · 2005

Jarmoskaite I · RNA (New York, N.Y.) · 2024

Recent

Europe PMC papers linked directly to this protein.